Aspen Neuroscience: Funding, Investors & Team (Oct 2026)
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
Aspen Neuroscience has raised $381M across 5 funding rounds on record, the most recent a Series C of $115M announced in Nov 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Aspen Neuroscience Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Aspen Neuroscience Funding Rounds
Aspen Neuroscience raised $70.0M in an undisclosed round announced in Apr 2020.
2.1 years later, a Series B of $148M was announced in May 2022.
7 months later, an undisclosed round of $40.0M was announced in Dec 2022.
1.4 years later, an undisclosed round of $8.0M was announced in May 2024.
1.5 years later, a Series C of $115M was announced in Nov 2025.
Aspen Neuroscience Founders and Leadership Team
Contact details for the Aspen Neuroscience team: 1 of 3 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Aspen Neuroscience Funding Compared to Other Biotechnology Startups
Aspen Neuroscience's latest round of $115M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Aspen Neuroscience in Biotechnology and San Diego
Companies Similar to Aspen Neuroscience
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Aspen Neuroscience Funding FAQs
What does Aspen Neuroscience do?
Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson’s disease (PD) and extending across the brain and affected organs.
How much funding has Aspen Neuroscience raised?
Aspen Neuroscience has raised $381M across 5 rounds on record. The most recent is a Series C of $115M announced in Nov 2025.
When did Aspen Neuroscience last raise funding?
Aspen Neuroscience's most recent funding round on record is a Series C of $115M, announced in Nov 2025.
Who founded Aspen Neuroscience?
FundedIQ lists Jeanne Loring (Founder) at Aspen Neuroscience.
Who is the CEO of Aspen Neuroscience?
Howard Federoff is listed as CEO at Aspen Neuroscience.
Where is Aspen Neuroscience headquartered?
Aspen Neuroscience is based in San Diego, California, United States.
How many employees does Aspen Neuroscience have?
Aspen Neuroscience is in the 51-100 employee band.
How does Aspen Neuroscience's funding compare to other Biotechnology startups?
Aspen Neuroscience's latest round of $115M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Aspen Neuroscience Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aspen Neuroscience is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.